Search for: "v. Teva Pharmaceuticals USA, Inc." Results 281 - 300 of 441
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Dec 2012, 3:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2012 WL 1866839, at *5 (W.D. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  In a December 2011 Complaint, several direct purchasers allege that Wyeth, acting alone and/or in concert with first generic applicant Teva Pharmaceuticals USA, Inc. [read post]
23 Aug 2012, 12:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2010 WL 8357563, slip op. at 1-2 (Tex. [read post]
30 May 2012, 8:28 am by Michelle Yeary
Teva Pharmaceuticals USA, Inc., 2012 U.S. [read post]
5 Apr 2012, 11:54 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
4 Mar 2012, 9:02 am by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
24 Jan 2012, 6:34 pm by FDABlog HPM
  Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
20 Sep 2011, 6:35 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734 (S.D. [read post]
16 Sep 2011, 8:17 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 U.S. [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
The court granted leave to file briefs amici curiae to Teva Pharmaceuticals, USA, Inc., Mylan Pharmaceuticals Inc., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en… [read post]